Earnings
FSTX
10.14
+9.03%
0.84
Currencies: USD
Items
Total Revenue
Revenue
Cost of Revenue
Gross Profit
Marketing and Administrative Expenses
Research and Development Costs
Financial Expenses
Depreciation and Amortization
Other Expenses
Total Operating Expenses
Asset Impairments
Operating Income
Interest Income
Assets Disposal
Other Non-operating Net Income
Non-operating Income
Net Income Before Taxes
Provision for Income Taxes
Net Income
Minority Interests
Net Income Attributable to Shareholders
Net Income Attributable to Common Equities
Net Income from Discontinued Operations
Basic EPS
Diluted EPS
FY 2020-12-31
11.26M
11.26M
--
--
19.51M
14.13M
--
--
--
33.64M
--
-22.39M
--
--
-3.23M
--
-25.62M
-1000.00
-25.62M
--
-25.62M
-25.62M
--
--
-9.69
FY 2019-12-31
0.00
0.00
--
--
9.75M
23.27M
--
--
--
33.02M
--
-33.02M
712.00K
--
8.21M
--
-24.10M
--
-24.10M
--
-24.10M
-24.10M
--
--
-5.86
FY 2018-12-31
0.00
0.00
--
--
8.72M
19.75M
--
--
--
28.47M
--
-28.47M
999.00K
--
4.62M
--
-22.85M
--
-22.85M
--
-22.85M
-22.85M
--
--
-6.36
FY 2017-12-31
0.00
0.00
--
--
8.18M
13.07M
--
--
--
21.25M
--
-21.25M
369.00K
--
-6.79M
--
-27.68M
--
-27.68M
--
-27.68M
-27.68M
--
--
-9.93
FY 2016-12-31
352.00K
352.00K
--
--
5.74M
14.02M
--
--
--
19.76M
--
-19.40M
96.00K
--
1.94M
--
-17.37M
--
-17.37M
--
-17.37M
-17.37M
--
--
-9.57

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out FSTX latest quarterly and annual financial reports. There are also past financial reports for you to reference. You can analyze F-star Therapeutics Inc recent business situations from balance sheets, income statements, cash flow statements and other tables. This information may help you make smarter investment decisions.